BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6876683)

  • 21. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies.
    Lindsey JW; Albers GW; Steinman L
    Ann Neurol; 1992 Sep; 32(3):407-9. PubMed ID: 1416813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myasthenia gravis in individuals over 40.
    Aarli JA; Romi F; Skeie GO; Gilhus NE
    Ann N Y Acad Sci; 2003 Sep; 998():424-31. PubMed ID: 14592910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune human T lymphocytes specific for acetylcholine receptor.
    Hohlfeld R; Toyka KV; Heininger K; Grosse-Wilde H; Kalies I
    Nature; 1984 Jul 19-25; 310(5974):244-6. PubMed ID: 6611507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thyroid disorders associated with myasthenia gravis].
    Lucas Martín A
    Med Clin (Barc); 1987 Nov; 89(16):684-8. PubMed ID: 3320602
    [No Abstract]   [Full Text] [Related]  

  • 27. Myasthenia gravis with autoimmune autonomic neuropathy.
    Vernino S; Cheshire WP; Lennon VA
    Auton Neurosci; 2001 May; 88(3):187-92. PubMed ID: 11474561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic factors in myasthenia gravis: a family study.
    Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
    Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myasthenia gravis associated with tonic pupil].
    Hagihara A; Sahashi K; Ibi T; Tsuchiya I; Mitsuma T
    Rinsho Shinkeigaku; 1990 Aug; 30(8):845-8. PubMed ID: 2253419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis with anti-acetylcholine receptor antibodies.
    Meriggioli MN
    Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset.
    Tiftikcioglu BI; Uludag IF; Zorlu Y; Pirim İ; Sener U; Tokucoglu F; Korucuk M
    Med Princ Pract; 2017; 26(1):71-77. PubMed ID: 27802446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis.
    Aharonov A; Abramsky O; Tarrab-Hazdai R; Fuchs S
    Lancet; 1975 Aug; 2(7930):340-2. PubMed ID: 51144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.
    Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H
    Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases].
    Toyka KV; Heininger K
    Dtsch Med Wochenschr; 1986 Sep; 111(38):1435-9. PubMed ID: 3757800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.